Sequential therapy in plaque psoriasis using the “ Hit and Run ” approach: infliximab followed by efalizumab

Immunotherapies in Dermatologic Disorders

“…77 Sequential therapy in plaque psoriasis after infliximab has been proposed with controversial results. 78,79 Efalizumab had been presented as an alternative therapy for discoid lupus erythematosus. However, some studies indicated successful results while others demonstrated induction of the disease.…”